ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2266

Outcome of Renal Transplantation in Lupus Patients with Positive and Negative Serology: Survival of the Graft and Patients After Transplant

Zahi Touma1, Murray B. Urowitz2, Dominique Ibanez2 and D. D. Gladman3, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Renal disease, systemic lupus erythematosus (SLE) and transplantation

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Lupus nephritis (LN) occurs in 50-75% of adults with SLE and up to 20% of LN patients may advance to end stage renal disease over a 10-year period.  The aims of this study were to provide an overview of the characteristics of lupus patients with renal transplantation (RT) followed in the Lupus Clinic between 1970-2012, and to determine the survival of the graft and patients after RT.

Methods:

Patients with lupus have been followed prospectively at the lupus clinic since 1970. Patients attend the clinic at 2-6 month intervals and the standard protocol includes: complete history, physical and laboratory evaluation. Patients who underwent RT were identified from the database. RT outcomes included: a) nonfunctional graft requiring dialysis within ≤3 weeks, b) graft failure requiring permanent dialysis after 3 weeks, c) graft survival not requiring dialysis and d) death.

Descriptive analysis was used to study the characteristics of all patients. We grouped the patients into graft failure and graft survival. The duration of graft failure was defined as the time between RT and subsequent permanent dialysis. The duration of graft survival was defined as the time between RT and recipient death or the end of the study with functioning graft.

 

Results:

25 (20 F) of 1645 patients followed in the lupus cohort and of 780 with renal involvement were identified with RT. 10 (40%) were Caucasian, 7 (28%) Black, 4 (16%) Asian and 4 (16%) others. The age at diagnosis of lupus and at transplant was 30.7±13.8 and 38.1±9.6 years respectively. Lupus duration at RT was 13.3±7.6 years.  2 (8%) patients had a nonfunctional graft, 4 (16%) patients had graft failure (1 patient had failure <5 years and 3 ≥5 years) and 19 (76%) patients had graft survival (8 had S ≥5 years) (Table 1). Patients with graft survival were older and had longer lupus duration compared to patients with failure at the time of RT. 25% of the graft failures had positive lupus serology compared to 47% in the graft survival 1 year prior to RT.

The time to graft failure (n=4) was 5.75±4.99y. In the failure group 3 patients died by 6±5.19 years and one patient is still alive. In the graft survival group 3 patients died by 5.6±4.6 years and one patient was lost of follow-up. Cause of death was not related to renal disease in 2patients and unknown in one patient.

Conclusion:

25 of 780 lupus nephritis patients followed at the Lupus Clinic underwent RT.   The persistence of serological abnormalities at the time of RT was not associated with graft failure.

            

Table 1. Characteristics if graft failure and graft survival patients.

 

Graft Failure

N=4

Graft survival

N=19

Sex

F 75%

F 84%

Age at lupus diagnosis

25.4±7.3

24.4±8.3

Age at transplant

29.8±9.1

40.0±9.5

Lupus duration at 1st clinic visit

5.9±4.0

7.2±7.8

Lupus duration at transplant

4.5±2.1

15.5±7.1

Ethnicity

                       Caucasian

                       Black

                       Asian

                       Others

 

1

1

2

0

 

7

6

2

4

Positive DNA in 1 year prior

1/4

5/18

Low complements in 1 year prior

1/4

9/19

Positive DNA and/or low complements in 1 year prior

1/4

9/19

Positive DNA and/or low complements in 1 year after transplant

2/3

8/19

SDI at transplant

4.0±0 (n=4)

4.6±1.9 (n=17)

Time (duration) on dialysis prior to transplant

3.9±2.4 (n=4)

5.8±5.6 (n=6)

 


Disclosure:

Z. Touma,
None;

M. B. Urowitz,
None;

D. Ibanez,
None;

D. D. Gladman,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2012

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcome-of-renal-transplantation-in-lupus-patients-with-positive-and-negative-serology-survival-of-the-graft-and-patients-after-transplant/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology